|
7.6
|
https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025
|
N/A
|
3
|
|
7.6
|
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
|
N/A
|
3
|
|
5.1
|
https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-warning-about-rare-severe-itching-after-stopping-long-term-use-oral-allergy-medicines
|
N/A
|
2
|
|
5.1
|
https://www.fda.gov/food/alerts-advisories-safety-information/fda-advises-public-not-eat-sell-or-serve-certain-imported-frozen-shrimp-indonesian-firm
|
N/A
|
2
|
|
5.1
|
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-serious-liver-disease-known-mash
|
N/A
|
2
|
|
5.1
|
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aquastar-usa-corp-recalls-kroger-mercado-frozen-cooked-shrimp-because-possible-health-risk
|
N/A
|
2
|
|
5.1
|
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/southwind-foods-llc-recalls-frozen-shrimp-because-possible-health-risk
|
N/A
|
2
|
|
5.1
|
https://www.fda.gov/food/generally-recognized-safe-gras/how-us-fdas-gras-notification-program-works
|
N/A
|
2
|
|
2.5
|
https://www.fda.gov/food/packaging-food-contact-substances-fcs/food-contact-substances-inventory
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/food/dietary-supplements
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-tryptyr
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-enflonsia
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/news-events/press-announcements/fda-advances-robust-transparent-post-market-chemical-review-program-keep-food-supply-safe-and
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-treat-adults-persistent-or-chronic-immune-thrombocytopenia
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/vaccines-blood-biologics/mnexspike
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/food/generally-recognized-safe-gras/fdas-approach-gras-provision-history-processes
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/tobacco-products/retail-sales-tobacco-products/selling-tobacco-products-retail-stores
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/news-events/press-announcements/fda-approves-first-immunotherapy-recurrent-respiratory-papillomatosis
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/vaccines-blood-biologics/papzimeos
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/drugs/information-consumers-and-patients-drugs/hiding-plain-sight-7-oh-products
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aquastar-usa-corp-recalls-cocktail-shrimp-6oz-because-possible-health-risk
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-zongertinib-non-squamous-nsclc-her2-tkd-activating-mutations
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-approves-required-updated-warning-labeling-mrna-covid-19-vaccines-regarding-myocarditis-and
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-taletrectinib-ros1-positive-non-small-cell-lung-cancer
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/safety/medical-product-safety-information/fda-update-safety-ixchiq-chikungunya-vaccine-live-fda-safety-communication
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/food/food-labeling-nutrition/overview-food-labeling
|
N/A
|
1
|
|
2.5
|
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-ibtrozi
|
N/A
|
1
|